Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian Cancer

NCT00181688 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer
Peritoneal Carcinoma
Tubal Carcinoma

Interventions

DRUG: Iressa (ZD1839)
DRUG: Arimidex (Anastrozole)

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]